跳至主要内容
临床试验/JPRN-jRCTs072180006
JPRN-jRCTs072180006已完成3 期

Evaluation of availability of linked color imaging compared to white light imaging colonoscopy for detection of colonic adenomas: a multicenter prospective study - LCI-detection study

Shimoda Ryo0 个研究点目标入组 678 人开始时间: 2018年11月12日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
678

研究概览

简要总结

A multicenter, randomized, back-to-back design study was conducted to compare LCI and WLI on the detection of colonic adenomas. The primary endpoint was the miss rate. The full analysis set was 327 and 320 in LCI-WLI group and WLI-LCI group, respectively. The mean miss rates were 9.3% and 20.6% in LCI-WLI group and WLI-LCI group, respectively, and it was statistically significant (Wilcoxon test, P<0.001). It was concluded that LCI was superior to WLI on detection of colonic adenomas.

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 <= 79age old(—)
性别
All

入选标准

  • 1) Lower GI endoscopy examinee who are between 18 and 79 years (at the time signing informed consent)
  • 2) Patients who understand the contents of informed consent form and who can voluntarily sign informed consent form (in the case of a minor, also informed consent from proxies)
  • 3) Patients who does not receive lower digestive tract endoscopy in the institute concerned for the past three years
  • 4) Patients requiring lower digestive tract endoscopy (meeting any of the following criteria)
  • (a)Positive fecal occult blood
  • (b)Subjects with diagnosis or treatment history of large intestine adenoma, colorectal cancer (it is ineligible if colon/rectum resection was undertaken)
  • (c)Subjects with digestive symptoms such as abdominal pain, diarrhea and constipation
  • (d)Subjects who requires the screening of gastrointestinal cancer
  • (e)Subjects with a family affection history of colorectal cancer and large intestine adenoma
  • (f)Any other subjects who are regarded that the investigator needed lower digestive tract endoscopy

排除标准

  • 1)Patients who have undergone intestinal resection
  • 2)Patients with a history of inflammatory bowel disease
  • 3)Patients with a history of familial adenomatous polyposis
  • 4)Patients with a history of hereditary nonpolyposis colorectal cancer
  • 5)Patients with severe intestinal adhesions known beforehand
  • 6)Patients who the investigator determined difficult to participate in the study

研究者

发起方
Shimoda Ryo

相似试验